Related Experiment Videos

Apolipoprotein and lipid abnormalities in uremic children on hemodialysis

Insights

Uremic children on hemodialysis show abnormal plasma lipids and apolipoproteins, similar to adults. These changes suggest a potential increased risk of cardiovascular disease in these young patients.

Area of Science:

  • Pediatric Nephrology
  • Clinical Biochemistry
  • Cardiovascular Risk Assessment

Background:

  • Uremia in children undergoing hemodialysis is associated with complex metabolic alterations.
  • Lipid and apolipoprotein profiles are critical indicators of cardiovascular health.

Purpose of the Study:

  • To investigate plasma lipid and apolipoprotein abnormalities in pediatric patients with uremia on hemodialysis.
  • To compare these findings with those in healthy controls and adult uremic populations.

Main Methods:

  • Analysis of plasma lipid levels (triglycerides, total cholesterol, HDL-cholesterol).
  • Quantification of six plasma apolipoproteins (Apo A-I, A-II, B, C-I, C-II, C-III).
  • Comparison of biochemical markers between uremic children and normal controls.

Main Results:

  • Uremic children exhibited significantly elevated plasma triglycerides and apolipoproteins C-II and C-III.
  • Decreased levels of total cholesterol, HDL-cholesterol, apolipoproteins A-I, A-II, and B were observed.
  • An increased ratio of (Apo A-I + Apo A-II)/HDL-cholesterol was noted.

Conclusions:

  • Pediatric uremia on hemodialysis is characterized by dyslipidemia and altered apolipoprotein profiles.
  • These lipid abnormalities mirror those seen in adult uremic patients, indicating a potential shared cardiovascular disease risk.
  • Further research into managing these metabolic derangements in children is warranted.

Related Concept Videos